1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA MPV17 CTRPv2 pan-cancer AAC -0.15 1e-05
mRNA ZNF711 CTRPv2 pan-cancer AAC 0.16 1e-05
mRNA TGS1 CTRPv2 pan-cancer AAC 0.15 1e-05
mRNA SLAIN1 CTRPv2 pan-cancer AAC 0.16 1e-05
mRNA CAMSAP1 CTRPv2 pan-cancer AAC 0.15 1e-05
mRNA NBPF14 CTRPv2 pan-cancer AAC -0.15 1e-05
mRNA USP11 CTRPv2 pan-cancer AAC 0.15 1e-05
mRNA CACNB3 CTRPv2 pan-cancer AAC 0.15 1e-05
mRNA RP1-27O5.3 CTRPv2 pan-cancer AAC 0.15 1e-05
mRNA GABPA CTRPv2 pan-cancer AAC 0.15 1e-05
Download CSV